Development of a Unique Anti-Aml Immune Therapy Consisting of Cord Blood HSCT and Cord Blood Stem Cell-Derived Dendritic Cell (CB-DC) Vaccination
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p206
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2013
Authors
Publisher
BMJ